A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity

Molecular Microbiology

Volumn 86, Issue 6, 2012, Pages 1531-1547

  Kryndushkin, Dmitry ^a   Ihrke, Gudrun ^a   Piermartiri, Tetsade C ^a   Shewmaker, Frank ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BTN2P PROTEIN; CARRIER PROTEIN; FUSED IN SARCOMA PROTEIN; OPTINEURIN; SUPEROXIDE DISMUTASE; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE MODEL; GAIN OF FUNCTION MUTATION; GENE MUTATION; GLAUCOMA; HUMAN; HUMAN CELL; NERVE CELL DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WILD TYPE;

AMINO ACID TRANSPORT SYSTEMS; CELL LINE; HUMANS; MUTANT PROTEINS; MUTATION, MISSENSE; PROTEIN DENATURATION; PROTEIN MULTIMERIZATION; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTOR TFIIIA;

EID: 84871013812     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.12075     Document Type: Article

References (70)

1. Aung, T., Rezaie, T., Okada, K., Viswanathan, A.C., Child, A.H., Brice, G., etal. (2005) Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 46: 2816-2822.
2. Ayscough, K.R., Stryker, J., Pokala, N., Sanders, M., Crews, P., and Drubin, D.G. (1997) High rates of actin filament turnover in budding yeast and roles for actin in establishment and maintenance of cell polarity revealed using the actin inhibitor latrunculin-A. J Cell Biol 137: 399-416.
3. Bond, L.M., Peden, A.A., Kendrick-Jones, J., Sellers, J.R., and Buss, F. (2011) Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane. Mol Biol Cell 22: 54-65.
4. Chi, Z.L., Akahori, M., Obazawa, M., Minami, M., Noda, T., Nakaya, N., etal. (2010) Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol Genet 19: 2606-2615.
5. Chibalina, M.V., Poliakov, A., Kendrick-Jones, J., and Buss, F. (2010) Myosin VI and optineurin are required for polarized EGFR delivery and directed migration. Traffic 11: 1290-1303.
6. De Marco, N., Buono, M., Troise, F., and Diez-Roux, G. (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 281: 16147-16156.
7. Deng, H.X., Chen, W., Hong, S.T., Boycott, K.M., Gorrie, G.H., Siddique, N., etal. (2011a) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477: 211-215.
8. Deng, H.X., Bigio, E.H., Zhai, H., Fecto, F., Ajroud, K., Shi, Y., etal. (2011b) Differential involvement of optineurin in amyotrophic lateral sclerosis with or without SOD1 mutations. Arch Neurol 68: 1057-1061.
9. Derkatch, I.L., Bradley, M.E., Hong, J.Y., and Liebman, S.W. (2001) Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 106: 171-182.
10. Elden, A.C., Kim, H.J., Hart, M.P., Chen-Plotkin, A.S., Johnson, B.S., Fang, X., etal. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466: 1069-1075.
11. Ganusova, E.E., Ozolins, L.N., Bhagat, S., Newnam, G.P., Wegrzyn, R.D., Sherman, M.Y., and Chernoff, Y.O. (2006) Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast. Mol Cell Biol 26: 617-629.
12. Gitler, A.D., and Shorter, J. (2011) RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5: 179-187.
13. Gong, H., Romanova, N.V., Allen, K.D., Chandramowlishwaran, P., Gokhale, K., Newnam, G.P., etal. (2012) Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast. PLoS Genet 8: e1002634.
14. Hattula, K., and Peranen, J. (2000) FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 10: 1603-1606.
15. Hortobagyi, T., Troakes, C., Nishimura, A.L., Vance, C., van Swieten, J.C., Seelaar, H., etal. (2011) Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol 121: 519-527.
16. Iida, A., Hosono, N., Sano, M., Kamei, T., Oshima, S., Tokuda, T., etal. (2012) Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese. Neurobiol Aging 33: 1843.e19-1843.e24.
17. Ince, P.G., Highley, J.R., Kirby, J., Wharton, S.B., Takahashi, H., Strong, M.J., and Shaw, P.J. (2011) Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol 122: 657-671.
18. Johnson, B.S., Snead, D., Lee, J.J., McCaffery, J.M., Shorter, J., and Gitler, A.D. (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284: 20329-20339.
19. Johnston, J.A., Ward, C.L., and Kopito, R.R. (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143: 1883-1898.
20. Ju, S., Tardiff, D.F., Han, H., Divya, K., Zhong, Q., Maquat, L.E., etal. (2011) A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol 9: e1001052.
21. Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J., Vande Velde, C., etal. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574.
22. Kachaner, D., Genin, P., Laplantine, E., and Weil, R. (2012) Toward an integrative view of Optineurin functions. Cell Cycle 11: 2808-2818.
23. Kaganovich, D., Kopito, R., and Frydman, J. (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454: 1088-1095.
24. Kama, R., Robinson, M., and Gerst, J.E. (2007) Btn2, a Hook1 ortholog and potential Batten disease-related protein, mediates late endosome-Golgi protein sorting in yeast. Mol Cell Biol 27: 605-621.
25. Karch, C.M., Prudencio, M., Winkler, D.D., Hart, P.J., and Borchelt, D.R. (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA 106: 7774-7779.
26. Khurana, V., and Lindquist, S. (2010) Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? Nat Rev Neurosci 11: 436-449.
27. Kryndushkin, D., and Shewmaker, F. (2011) Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity. Prion 5: 250-257.
28. Kryndushkin, D., Wickner, R.B., and Shewmaker, F. (2011) FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein Cell 2: 223-236.
29. Kryndushkin, D.S., Shewmaker, F., and Wickner, R.B. (2008) Curing of the [URE3] prion by Btn2p, a Batten disease-related protein. EMBO J 27: 2725-2735.
30. Kwiatkowski, T.J., Jr, Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., etal. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
31. Lagier-Tourenne, C., and Cleveland, D.W. (2009) Rethinking ALS: the FUS about TDP-43. Cell 136: 1001-1004.
32. Lagier-Tourenne, C., Polymenidou, M., and Cleveland, D.W. (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19: R46-R64.
33. Li, Y., Kang, J., and Horwitz, M.S. (1998) Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 18: 1601-1610.
34. Lobley, A., Whitmore, L., and Wallace, B.A. (2002) DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics 18: 211-212.
35. Luiro, K., Yliannala, K., Ahtiainen, L., Maunu, H., Jarvela, I., Kyttala, A., and Jalanko, A. (2004) Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum Mol Genet 13: 3017-3027.
36. McGlinchey, R.P., Kryndushkin, D., and Wickner, R.B. (2011) Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci USA 108: 5337-5341.
37. Malinovska, L., Kroschwald, S., Munder, M.C., Richter, D., and Alberti, S. (2012) Molecular chaperones and stress-inducible protein sorting factors coordinate the spatio-temporal distribution of protein aggregates. Mol Biol Cell 23: 3041-3056.
38. Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., etal. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223-226.
39. Mathur, V., Taneja, V., Sun, Y., and Liebman, S.W. (2010) Analyzing the birth and propagation of two distinct prions, [PSI+] and [Het-s](y), in yeast. Mol Biol Cell 21: 1449-1461.
40. Meng, Q., Lv, J., Ge, H., Zhang, L., Xue, F., Zhu, Y., and Liu, P. (2012) Overexpressed mutant optineurin(E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway. Mol Biol Rep 39: 5867-5873.
41. Meriin, A.B., Zhang, X., He, X., Newnam, G.P., Chernoff, Y.O., and Sherman, M.Y. (2002) Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 157: 997-1004.
42. Muchowski, P.J., Schaffar, G., Sittler, A., Wanker, E.E., Hayer-Hartl, M.K., and Hartl, F.U. (2000) Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA 97: 7841-7846.
43. Nagabhushana, A., Chalasani, M.L., Jain, N., Radha, V., Rangaraj, N., Balasubramanian, D., and Swarup, G. (2010) Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol 11: 4.
44. Okita, S., Morigaki, R., Koizumi, H., Kaji, R., Nagahiro, S., and Goto, S. (2011) Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease. Neuroscience 202: 363-370.
45. Olzmann, J.A., Li, L., and Chin, L.S. (2008) Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 15: 47-60.
46. Osawa, T., Mizuno, Y., Fujita, Y., Takatama, M., Nakazato, Y., and Okamoto, K. (2011) Optineurin in neurodegenerative diseases. Neuropathology 31: 569-574.
47. Park, B., Ying, H., Shen, X., Park, J.S., Qiu, Y., Shyam, R., and Yue, B.Y. (2010) Impairment of protein trafficking upon overexpression and mutation of optineurin. PLoS ONE 5: e11547.
48. Park, B.C., Shen, X., Samaraweera, M., and Yue, B.Y. (2006) Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol 169: 1976-1989.
49. Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., etal. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079.
50. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., etal. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
51. Ross, C.A., and Poirier, M.A. (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 (Suppl.): S10-S17.
52. Sahlender, D.A., Roberts, R.C., Arden, S.D., Spudich, G., Taylor, M.J., Luzio, J.P., etal. (2005) Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 169: 285-295.
53. Shen, X., Ying, H., Qiu, Y., Park, J.S., Shyam, R., Chi, Z.L., etal. (2011) Processing of optineurin in neuronal cells. J Biol Chem 286: 3618-3629.
54. Shewmaker, F., Wickner, R.B., and Tycko, R. (2006) Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc Natl Acad Sci USA 103: 19754-19759.
55. Specht, S., Miller, S.B., Mogk, A., and Bukau, B. (2011) Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. J Cell Biol 195: 617-629.
56. Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., etal. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672.
57. Su, L.J., Auluck, P.K., Outeiro, T.F., Yeger-Lotem, E., Kritzer, J.A., Tardiff, D.F., etal. (2010) Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis Model Mech 3: 194-208.
58. Sun, Z., Diaz, Z., Fang, X., Hart, M.P., Chesi, A., Shorter, J., and Gitler, A.D. (2011) Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol 9: e1000614.
59. Szebenyi, G., Wigley, W.C., Hall, B., Didier, A., Yu, M., Thomas, P., and Kramer, H. (2007) Hook2 contributes to aggresome formation. BMC Cell Biol 8: 19.
60. Treusch, S., and Lindquist, S. (2012) An intrinsically disordered yeast prion arrests the cell cycle by sequestering a spindle pole body component. J Cell Biol 197: 369-379.
61. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., etal. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208-1211.
62. Vishveshwara, N., Bradley, M.E., and Liebman, S.W. (2009) Sequestration of essential proteins causes prion associated toxicity in yeast. Mol Microbiol 73: 1101-1114.
63. Wang, Y., Meriin, A.B., Zaarur, N., Romanova, N.V., Chernoff, Y.O., Costello, C.E., and Sherman, M.Y. (2009) Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 23: 451-463.
64. Weimer, J.M., Chattopadhyay, S., Custer, A.W., and Pearce, D.A. (2005) Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1. Biochem Biophys Res Commun 330: 1176-1181.
65. Wild, P., Farhan, H., McEwan, D.G., Wagner, S., Rogov, V.V., Brady, N.R., etal. (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333: 228-233.
66. Winderickx, J., Delay, C., De Vos, A., Klinger, H., Pellens, K., Vanhelmont, T., etal. (2008) Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim Biophys Acta 1783: 1381-1395.
67. Wong, E.S., Tan, J.M., Soong, W.E., Hussein, K., Nukina, N., Dawson, V.L., etal. (2008) Autophagy-mediated clearance of aggresomes is not a universal phenomenon. Hum Mol Genet 17: 2570-2582.
68. Ying, H., and Yue, B.Y. (2012) Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol 294: 223-258.
69. Zhou, P., Derkatch, I.L., and Liebman, S.W. (2001) The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion-like elements [PSI(+)] and [PIN(+)]. Mol Microbiol 39: 37-46.
70. Zinman, L., and Cudkowicz, M. (2011) Emerging targets and treatments in amyotrophic lateral sclerosis. Lancet Neurol 10: 481-490.